User profiles for Sylvain A Lother
 | Sylvain LotherUniversity of Manitoba Verified email at umanitoba.ca Cited by 6395 |
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …
Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19
Importance Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
…, AA Nascene, ML Axelrod, SA Lother… - Open forum …, 2020 - academic.oup.com
Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
Ramping up the delivery of cardiac surgery during the COVID-19 pandemic: a guidance statement from the Canadian Society of Cardiac Surgeons
The coronavirus disease 2019 (COVID-19) has had a profound global effect. Its rapid
transmissibility has forced whole countries to adopt strict measures to contain its spread. As part of …
transmissibility has forced whole countries to adopt strict measures to contain its spread. As part of …
[HTML][HTML] Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic …
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there …
in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there …
Preoperative SARS-CoV-2 screening: Can it really rule out COVID-19?
SA Lother - Canadian Journal of Anesthesia/Journal canadien d' …, 2020 - Springer
Expanded indications for testing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been recommended as health systems emerge from pandemic-related …
have been recommended as health systems emerge from pandemic-related …
[HTML][HTML] Clonal clusters and virulence factors of group C and G Streptococcus causing severe infections, Manitoba, Canada, 2012–2014
The incidence of group C and G Streptococcus (GCGS) bacteremia, which is associated with
severe disease and death, is increasing. We characterized clinical features, outcomes, and …
severe disease and death, is increasing. We characterized clinical features, outcomes, and …
Surgical triage and timing for patients with coronavirus disease: a guidance statement from the Society of Thoracic Surgeons
The coronavirus disease 2019 (COVID-19) pandemic continues to disrupt the provision of
cardiac procedural services due to overwhelming interval surges in COVID-19 cases and the …
cardiac procedural services due to overwhelming interval surges in COVID-19 cases and the …
